<DOC>
	<DOCNO>NCT01596088</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety KDX-0811 ( Dexrazoxane ) treatment accidental extravasation anthracycline anti-cancer agent .</brief_summary>
	<brief_title>A Phase I/II Study KDX-0811 ( Dexrazoxane ) Treatment Accidental Extravasation Anthracycline Anti-cancer Agents</brief_title>
	<detailed_description />
	<mesh_term>Antineoplastic Agents</mesh_term>
	<mesh_term>Dexrazoxane</mesh_term>
	<mesh_term>Razoxane</mesh_term>
	<criteria>Patients suspect exposed extravasation anthracycline Patients reasonably suspect exposed extravasation compound anthracyclines IV access , e.g . vincristine , mitomycin , vinorelbine , may cause ulceration</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Extravasation</keyword>
	<keyword>Anthracyclines</keyword>
</DOC>